Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: A SPECT study

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 661-669

  Seo, Ho Jun ^a   Choi, Young Hee ^b   Chung, Yong An ^a   Rho, Wangku ^a   Chae, Jeong Ho ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Metta Institute of Cognitive Behavior Therapy   (South Korea)

Author keywords

Anxiety; Brain activity; Neural correlate; Single photon emission computed tomography (SPECT)

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADULT; ANXIETY; ANXIETY SENSITIVITY INDEX REVISED; ARTICLE; BRAIN BLOOD FLOW; BRIEF BODY SENSATION INTERPRETATION QUESTIONNAIRE; CLINICAL ARTICLE; COGNITIVE THERAPY; FEMALE; GAMMA CAMERA; HUMAN; INFERIOR FRONTAL GYRUS; LEFT HEMISPHERE; MALE; PANIC; PANIC AND AGOROPHOBIC SCALE; PONS; POSTCENTRAL GYRUS; PRIMARY MOTOR CORTEX; QUESTIONNAIRE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84898940858     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S58660     Document Type: Article

References (44)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet. 2006;368:1023-1032.
3. Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 1986;24:1-8.
4. Bouton ME, Mineka S, Barlow DH. A modern learning theory perspective on the etiology of panic disorder. Psychol Rev. 2001;108: 4-32.
5. Clark DM. A cognitive approach to panic. Behav Res Ther. 1986;24: 461-470.
6. Andrisano C, Chiesa A, Serretti A. Newer antidepressants and panic disorder: a meta-analysis. Int Clin Psychopharmacol. 2013;28:33-45.
7. Ballenger JC, Burrows GD, DuPont RL Jr, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry. 1988;45:413-422.
8. Rosenbaum JF, Moroz G, Bowden CL. Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group. J Clin Psychopharmacol. 1997;17:390-400.
9. Simon NM, Safren SA, Otto MW, Sharma SG, Lanka GD, Pollack MH. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. J Affect Disord. 2002;69:201-208.
10. Toni C, Perugi G, Frare F, et al. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Pharmacop-sychiatry. 2000;33:121-131.
11. Pollack MH, Otto MW, Tesar GE, Cohen LS, Meltzer-Brody S, Rosenbaum JF. Long-term outcome after acute treatment with alpra-zolam or clonazepam for panic disorder. J Clin Psychopharmacol. 1993;13:257-263.
12. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA. 2000;283:2529-2536.
13. Loerch B, Graf-Morgenstern M, Hautzinger M, et al. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. Br J Psychiatry. 1999;174:205-212.
14. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000;157:493-505.
15. Eren I, Tükel R, Polat A, Karaman R, Unal S. Evaluation of regional cerebral blood fow changes in panic disorder with Tc99m-HMPAO SPECT. Psychiatry Res. 2003;123:135-143.
16. Garakani A, Buchsbaum MS, Newmark RE, et al. The effect of doxapram on brain imaging in patients with panic disorder. Eur Neuropsychopharmacol. 2007;17:672-686.
17. Vythilingam M, Anderson ER, Goddard A, et al. Temporal lobe volume in panic disorder - a quantitative magnetic resonance imaging study. Psychiatry Res. 2000;99:75-82.
18. Kircher T, Arolt V, Jansen A, et al. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol Psychiatry. 2013;73:93-101.
19. Prasko J, Horácek J, Záleský R, et al. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett. 2004;25:340-348.
20. Sakai Y, Kumano H, Nishikawa M, et al. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage. 2006;33:218-226.
21. Shurick AA, Gross JJ. Emotional reactivity and regulation in panic disorder: insights from a functional magnetic resonance imaging study of cognitive behavioral therapy. Biol Psychiatry. 2013;73:5-6.
22. Sheehan D V, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33.
23. Yoo S W, Kim YS, Noh JS, et al. Validity of Korean version of the mini-international neuropsychiatric interview. Anxiety and Mood. 2006;2: 50-55.
24. Bandelow B. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol. 1995;10:73-81.
25. Choi YS. Effects of Group Cognitive Behavioral Therapy on Body Sensation Interpretation, Anxiety Control and Panic/Agoraphobic Symptoms in Patients with Panic Disorder. [dissertation]. Seoul: Catholic University; 2007.
26. Taylor S, Cox BJ. An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord. 1998;12(5):463-483.
27. Kim JH, Yu BH, Oh KS, et al. A validation study of Korean Anxiety Sensitivity Index - Revised (ASI-R). J Korean Neuropsychiatr Assoc. 2004;43:54-61.
28. Clark DM, Salkovskis PM, Ost LG, et al. Misinterpretation of body sensations in panic disorder. J Consult Clin Psychol. 1997;65:203-213.
29. Kim SJ. Reliability and Validity of the Korean Version of the Brief Body Sensation Interpretation questionnaire. [dissertation]. Chuncheon: Hallym University; 2006.
30. Rapee RM, Craske MG, Brown TA, Barlow DH. Measurement of perceived control over anxiety-related events. Behav Ther. 1996;27: 279-293.
31. Cho YR, Kim EJ. Psychometric properties of the Korean version of the Anxiety Control Questionnaire. Korean J Clin Psychol. 2004;23(2): 503-518.
32. Chung YA, O JH, Kim JY, Kim KJ, Ahn KJ. Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med. 2009;50:1969-1974.
33. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci. 2001;4:95-102.
34. Paulus MP, Stein MB. An insular view of anxiety. Biol Psychiatry. 2006;60:383-387.
35. Javanmard M, Shlik J, Kennedy SH, Vaccarino FJ, Houle S, Bradwejn J. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol Psychiatry. 1999;45: 872-882.
36. Reiman EM, Raichle ME, Robins E, et al. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry. 1989;46: 493-500.
37. Barlow DH. Cognitive-behavioral therapy for panic disorder: current status. J Clin Psychiatry. 1997;58 Suppl 2:32-36.
38. Ochsner KN, Ray RD, Cooper JC, et al. For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage. 2004;23:483-499.
39. Coplan JD, Papp LA, Pine D, et al. Clinical improvement with fuoxetine therapy and noradrenergic function in patients with panic disorder. Arch Gen Psychiatry. 1997;54:643-648.
40. Stutzmann GE, LeDoux JE. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci. 1999;19:RC8.
41. Linden DE. How psychotherapy changes the brain - the contribution of functional neuroimaging. Mol Psychiatry. 2006;11:528-538.
42. Schienle A, Schäfer A, Stark R, Vaitl D. Long-term effects of cognitive behavior therapy on brain activation in spider phobia. Psychiatry Res. 2009;172:99-102.
43. Kim BN, Lee JS, Shin MS, Cho SC, Lee DS. Regional cerebral perfusion abnormalities in attention defcit/hyperactivity disorder. Statistical parametric mapping analysis. Eur Arch Psychiatry Clin Neurosci. 2002;252:219-225.
44. McGoron AJ, Capille M, Georgiou MF, et al. Post traumatic brain perfusion SPECT analysis using reconstructed ROI maps of radioactive microsphere derived cerebral blood fow and statistical parametric mapping. BMC Med Imaging. 2008;8:4-15.